Progesterone downregulates the expression of DSCAM-AS1 specifically in PR-positive breast cancer cells, wherein PR modulates the genomic binding pattern of ER, the classical activator of DSCAM-AS1 [27], in response to progesterone. The gene discussed is PGR; the disease is breast cancer.